Drug manufacturers owe a duty of care to their patients. They must explain all risks associated with their medications — and if a manufacturer fails to disclose certain risks, they may be liable for the damages their patients suffer. Current litigation against Eisai, Inc. alleges that the manufacturer failed to warn patients that its weight loss drugs Belviq and Belviq XR may raise the risk of certain cancers.
If you developed cancer after taking Belviq, you may be eligible for financial compensation. The attorneys at Shapiro Legal Group, PLLC can help you secure the compensation you need to recover from your damages.
Why Choose Us
- We have over 25 years of experience in mass tort and personal injury litigation, with a focus on dangerous and defective products.
- Our firm has developed relationships with expert witnesses who can testify on your behalf, validating your claims and helping prove the presence of negligence.
- Our firm provides legal representation nationwide, working with leading personal injury and mass tort firms to help secure the compensation you deserve.
Belviq Raises the Risk of Cancer Among Patients
It is common for the FDA to require drug manufacturers conduct additional studies after the agency approves their medications for consumer use. Since weight loss drugs often have heart-related side effects, the FDA asked Eisai, Inc. to examine the impact Belviq and Belviq XR had on cardiovascular health.
In February 2020, the FDA asked Eisai, Inc. to withdraw Belviq from the market after the company released the post-approval study. Although the results revealed no adverse effects on heart health, there was an elevated risk of cancer among Belviq patients. 7.1% of patients in the placebo group developed cancer, while 7.7% of Belviq users developed cancer over the same time period.
Who Is Eligible for a Belviq Lawsuit?
Only certain patients qualify for Belviq lawsuits. First, you must have developed one of the following types of cancer within seven years of taking Belviq.
- Pancreatic cancer
- Lung cancer
- Colon or colorectal cancer
You will also need to have taken Belviq for at least six months, which do not have to be in a row. For example, if you took Belviq for three months, skipped for two months, and resumed use for at least three more months, you would likely qualify for litigation.
Why Should You File a Belviq Lawsuit?
Cancer can have a devastating impact on your health and well-being. You will need to undergo extensive treatment that your insurance may not cover, missing hours of work and valuable time with your loved ones. The mental and physical toll of cancer can also impact your quality of life and ability to enjoy the activities you once loved.
If Belviq is the cause of your cancer diagnosis, you deserve compensation to aid in your recovery. Filing a lawsuit against Eisai, Inc. allows you to collect compensatory damages for the losses you sustained due to your cancer, including the following.
- Past and future medical expenses
- Lost wages and loss of future earnings
- Loss of quality of life
- Emotional distress and mental anguish
- Chronic pain
Contact a Minnesota Belviq Lawyer
If you are a former Belviq patient, you deserve justice. You may be eligible to file a lawsuit against Eisai, Inc. if you developed colorectal, lung, or pancreatic cancer within seven years after taking this medication. As soon as you believe you may qualify for litigation, speak to an attorney at Shapiro Legal Group.
Our firm represents Minnesota residents in their Belviq injury lawsuits. Contact us today to schedule your free consultation and discuss your next steps.